Newsfeeds - Spark Newswire

2 minute read

Mid-Afternoon Market Update: Dow Falls 70 Points; Evolving Systems Shares Spike Higher

Today, 10:56 AM

Toward the end of trading Monday, the Dow traded down 0.20% to 35,223.86 while the NASDAQ rose 0.68% to 14,998.54. The S&P also rose, gaining 0.19% to 4,480.05.

ACI

2 minute read

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

Today, 10:56 AM

ADMP

2 minute read

Mid-Day Market Update: Nasdaq Rises 50 Points; Revance Therapeutics Shares Plummet

By Lisa Levin

Today, 10:56 AM

Midway through trading Monday, the Dow traded down 0.05% to 35,275.96 while the NASDAQ rose 0.34% to 14,948.46. The S&P also rose, gaining 0.19% to 4,479.71.

AAP

3 minute read

34 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 10:56 AM

Gainers Valneva SE (NASDAQ: VALN) shares jumped 34.6% to $37.75 after the company reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial Cov-Compare.

AGRX

2 minute read

Mid-Morning Market Update: Markets Mostly Lower; Albertsons Tops Q2 Estimates

By Lisa Levin

Today, 10:56 AM

Following the market opening Monday, the Dow traded down 0.32% to 35,182.99 while the NASDAQ rose 0.12% to 14,915.84. The S&P also fell, dropping 0.06% to 4,468.81.

ACI

2 minute read

Mid-Morning Market Update: Markets Mostly Lower; Albertsons Tops Q2 Estimates

By Lisa Levin

Today, 10:56 AM

Following the market opening Monday, the Dow traded down 0.32% to 35,182.99 while the NASDAQ rose 0.12% to 14,915.84. The S&P also fell, dropping 0.06% to 4,468.81.

ACI

1 minute read

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

Today, 10:56 AM

ADMP

2 minute read

21 Stocks Moving in Monday’s Pre-Market Session

By Lisa Levin

Today, 10:56 AM

Gainers Valneva SE (NASDAQ: VALN) rose 34.4% to $37.69 in pre-market trading after the company disclosed positive Phase 3 results for inactivated, adjuvanted COVID-19 vaccine candidate VLA2001.

ABUS

4 minute read

Valneva Reports Phase 3 Results for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001 Met Both Co-primary Endpoints

By Charles Gross

Today, 10:56 AM

Valneva SE (NASDAQ: VALN) today announced positive topline results from the Phase 3 pivotal trial Cov-Compare of its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001.

DVAX

1 minute read

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

Today, 10:56 AM

Gainers Protagonist Therapeutics (NASDAQ:PTGX) shares moved upwards by 89.3% to $34.53 during Monday's pre-market session. The market value of their outstanding shares is at $1.6 billion.

ADMS